✦ LIBER ✦

No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes

✍ Scribed by Jerry J. Jaboin; Misun Hwang; Carmen A. Perez; Calvin Cooper; Heidi Chen; Chuanzhong Ye; Qiuyin Cai; Marcia L. Wills; Bo Lu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mdm2-SNP309 polymorphism in prostate can

✍ Stoehr, R; Hitzenbichler, F; Kneitz, B; Hammerschmied, C G; Burger, M; Tannapfel 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

No association of the MDM2 SNP309 polymo

✍ Ian G Campbell; Diana M Eccles; David Y.H. Choong 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

P218 The association of MDM2 T309G with

✍ Ismail, S.M.; Hamid, S.; Yang, Y.H.; Ghani, W.M.N.; Lim, K.P.; Ng, L.P.K.; Zain, 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 51 KB

The MDM2 promoter polymorphism SNP309T->

✍ Alhopuro, P 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 80 KB

The TP53 Arg72Pro and MDM2 309G>T polymo

✍ Sinilnikova, O M; Antoniou, A C; Simard, J; Healey, S; Léoné, M; Sinnett, D; Spu 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

A functional polymorphism T309G in MDM2

✍ Xiaolin Pan, Yuqin Li, Jin Feng, Xiaoyong Wang, Bo Hao, Ruihua Shi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 299 KB